CureMatch
×
  • Physicians
  • Patients
  • Employers
  • Order
  • News
  • About Us
  • Login
Igor Tsigelny, PhD

Igor Tsigelny, PhD

CO-FOUNDER ADVISOR

Igor originally developed the CureMatch technology while serving as Research Professor at the Department of Neurosciences, San Diego Supercomputer Center, and Moore’s Cancer Center (MCC). He is a member of the Molecular Tumor Board of the MCC, and is a recognized expert in molecular mechanisms of disease, structural biology, molecular modeling, bioinformatics and structure-based drug design.

Dr. Tsigelny has authored over 200 papers in peer-reviewed journals including Nature, Science, and Proceedings of National Academy of Sciences. He has designed three drug-candidates—aimed at Parkinson’s disease, brain cancer, and hypertension—which have all been licensed by UCSD to pharmaceutical companies and are in various stages of development.

logo

+1 (858) 284-0488

FAX: +1 (858) 430-5813

Quick Links

  • Home
  • Physicians
  • About CureMatch
  • News and Latest Posts
  • Contact Us
  • FAQ

Latest News and Results

  • The Complex Cancer Puzzle | Video 1 May 31

  • CureMatch and Mprobe Partner to Help Cancer Patients Determine Optimal Treatments Mar 27

    CureMatch will leverage mProbe’s targeted proteomics platform to assess individual proteins within patients’ tumor tissues....

  • CureMatch Granted CPT® Code by American Medical Association for its Algorithmic Cancer Therapy Ranking Service Jan 4

    Oncologists will be able to submit claims to payers using a Category III CPT code,...

© 2023 CureMatch, Inc. CureMatch is a registered trademark.
Terms of Use | Privacy Policy | HIPAA Notice

We’d like to send you a CureMatch Sample Analysis

 

Sample Analysis Download Form

  • This field is for validation purposes and should be left unchanged.

 

We value and respect your privacy and will not publish, share, or sell your contact information.

View Privacy Policy

Some pages of this website are intended for healthcare professionals

This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.

Otherwise, you will be redirected to the institutional part of this website.

Thank you for your understanding.

I am a healthcare professionalI am not a healthcare professional

Get ready to utilize the latest genomics data in your practice

Rank the most promising systemic therapies for your patients

Do you need to filter out those therapies with poor outcomes

Sort through 4.5 million expertly curated combinations of drugs

Compute your own drug choices alongside CureMatch data